Order MiniMed™ 780G System | Medtronic

MiniMed™ 780G insulin pump system

 

Product code:MMT-1894

  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System
  • MiniMed™ 780G System

Product information

The MiniMed™ 780G system is our most advanced insulin delivery system that helps keep glucose levels in range for more consistency and fewer surprises, now compatible with the 15-day Instinct sensor, made by Abbott, and our 7-day infusion set.


Features

  • Meal Detection™ technology† — If you miss a meal dose or undercount carbs, the system automatically delivers correction‡ doses to stabilize your glucose levels.§
  • SmartGuard™ technology — Helps prevent highs and lows with automatic insulin adjustments every 5 minutes all day and night.§
  • Treat to target — Flexible glucose targets as low as 100 mg/dL.◊


What comes with your MiniMed™ 780G system:

Insulin pump
Based on info received from the CGM every 5 minutes, the pump makes automatic adjustments and corrections to your insulin delivery.

Continuous glucose monitor
The sensor measures glucose levels, sending readings to the pump with no fingersticks when using SmartGuard™ technology. Sold separately.

Instinct sensors are labeled for type 1 diabetes. Guardian™ 4 and Simplera™ Sync sensors are labeled for type 1 and type 2 diabetes.

Infusion set
The infusion set allows for continuous and discreet delivery of insulin through a thin, flexible tube. The Medtronic Extended™ infusion set can be worn up to 7 days. Other options available. Sold separately.

Accu-Chek® Guide Link blood glucose meter
Made by Roche, this is the only meter that is approved for use with the MiniMed™ 780G system.

Silicone pump skin
Silicone skin covers and protects your insulin pump. May be used with pump clip.

Blue adapter
USB adapter used to upload your MiniMed™ data to CareLink™ Personal.

Mobile apps
Get notified of highs and lows with the MiniMed™ Mobile app. Care partners can download the CareLink™ app to stay in the know.


Getting started on the MiniMed™ 780G system
If you’re ready to upgrade, Sign in to see your system upgrade offers. After submitting your request, an agent will reach out to you and answer any questions you may have.

Is this your first Medtronic insulin pump? Fill out an interest form.

MiniMed™ 780G insulin pump system

Product code:MMT-1894

Quantity: 1

Price varies
pending insurance



Choose your CGM:

Instinct Simplera G4S

Instinct sensor, made by Abbott

New! Designed to be worn up to 15 days. This all-in-one design is smaller than two stacked pennies.

Covered by most insurance

Prescription required


Product information

The MiniMed™ 780G system is our most advanced insulin delivery system that helps keep glucose levels in range for more consistency and fewer surprises, now compatible with the 15-day Instinct sensor, made by Abbott, and our 7-day infusion set.


Features

  • Meal Detection™ technology† — If you miss a meal dose or undercount carbs, the system automatically delivers correction‡ doses to stabilize your glucose levels.§
  • SmartGuard™ technology — Helps prevent highs and lows with automatic insulin adjustments every 5 minutes all day and night.§
  • Treat to target — Flexible glucose targets as low as 100 mg/dL.◊


What comes with your MiniMed™ 780G system:

Insulin pump
Based on info received from the CGM every 5 minutes, the pump makes automatic adjustments and corrections to your insulin delivery.

Continuous glucose monitor
The sensor measures glucose levels, sending readings to the pump with no fingersticks when using SmartGuard™ technology. Sold separately.

Instinct sensors are labeled for type 1 diabetes. Guardian™ 4 and Simplera™ Sync sensors are labeled for type 1 and type 2 diabetes.

Infusion set
The infusion set allows for continuous and discreet delivery of insulin through a thin, flexible tube. The Medtronic Extended™ infusion set can be worn up to 7 days. Other options available. Sold separately.

Accu-Chek® Guide Link blood glucose meter
Made by Roche, this is the only meter that is approved for use with the MiniMed™ 780G system.

Silicone pump skin
Silicone skin covers and protects your insulin pump. May be used with pump clip.

Blue adapter
USB adapter used to upload your MiniMed™ data to CareLink™ Personal.

Mobile apps
Get notified of highs and lows with the MiniMed™ Mobile app. Care partners can download the CareLink™ app to stay in the know.


©2025 Medtronic. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image © 2025 Abbott. ™*Third–party brands are trademarks of their respective owners.


Smart devices sold separately. For a list of compatible devices, refer to user guide.
† Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
‡ Refers to auto correct, which provides bolus assistance. Can deliver all correction doses automatically without user interaction, feature can be turned on and off.
§ Refers to SmartGuard™ feature. Individual results may vary.
◊ Glucose targets should be chosen following a consultation with your healthcare provider.
¶ Fingersticks required in manual mode & to enter smartguard. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard.
References
1. Data on file, Abbott Diabetes Care, Inc.


IMPORTANT SAFETY INFORMATION: MINIMED™ 780G SYSTEM WITH INSTINCT SENSOR

The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G System includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Instinct sensor can be used one time and has a life up to 15 days. The Instinct sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G system is operating in manual mode. All therapy adjustments in Manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Instinct sensor. The Instinct sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Only apply the sensor to the back of your upper arm. The sensor may not work properly in other areas.

The Medtronic MiniMed™ 780G System consists of the following devices: MiniMed™ 780G Insulin Pump and the Instinct sensor. The system requires a prescription from a healthcare professional.

WARNING:Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of atleast 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.


IMPORTANT SAFETY INFORMATION: MINIMED™ 780G SYSTEM WITH SMARTGUARD™ TECHNOLOGY WITH SIMPLERA SYNC™ SENSOR

The MiniMed™ 780G system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Simplera Sync™ sensor can be used one time and has a life up to 6 days, followed by a grace period of 24 hours. During the grace period, the sensor will continue to work as it did during the first 6 days, to allow the patient to change their sensor more flexibly. However, some sensors may not survive the full wear period for a variety of reasons. Please be prepared to replace the sensor during the grace period to ensure sensor glucose values continue to be monitored.

The Simplera Sync™ sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in Manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Simplera Sync™ sensor. The Simplera Sync™ sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Simplera Sync™ sensor in the abdomen or other body sites, including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

The Medtronic MiniMed™ 780G System consists of the following devices: MiniMed™ 780G Insulin Pump, Simplera Sync™ sensor, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide Test Strips. The system requires a prescription from a healthcare professional.



WARNING:Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of atleast 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.


IMPORTANT SAFETY INFORMATION: MINIMED™ 780G SYSTEM WITH SMARTGUARD™ TECHNOLOGY WITH GAURDIAN™ 4 SENSOR

The MiniMed™ 780G system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G Insulin Pump, the Guardian™ 4 Transmitter, the Guardian™ 4 Sensor, One-press serter, the Accu-Chek™Guide Link blood glucose meter, and the Accu-Chek™Guide Test Strips. The system requires a prescription from a healthcare professional.

The Guardian™ 4 Sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ (4) sensor is indicated for up to seven days of continuous use.

The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.



WARNING:Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of atleast 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.

WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library.

IMPORTANT SAFETY INFORMATION: MEDTRONIC EXTENDED™ INFUSION SET

It is NOT indicated for intravenous (IV) infusion or the infusion of blood or blood products. Inaccurate medication delivery, infection and/or site irritation may result from improper insertion and maintenance of the infusion site. Before insertion, clean the insertion site with isopropyl alcohol. Remove the needle guard before inserting the infusion set. If using this infusion set for the first time, do the first set-up in the presence of your healthcare professional. Do not leave air in the infusion set. Prime completely. Check frequently to make sure the soft cannula remains firmly in place as you may not feel pain if it pulls out. The soft cannula must always be completely inserted to receive the full amount of medication. If the infusion site becomes inflamed, replace the set, and use a new site until the first site has healed. Replace the infusion set if the tape becomes loose, or if the soft cannula becomes fully or partially dislodged from the skin. Regularly replace the infusion set as indicated in the instructions for use, or per the insulin labeling, whichever duration is shorter. For more details, see https://www.medtronicdiabetes.com/important-safety-information. 

IMPORTANT SAFETY INFORMATION: MEDTRONIC MOBILE APP

The MiniMed™ Mobile app is intended to provide a secondary display for a compatible MiniMed™ insulin pump system on a suitable consumer electronic device for passive monitoring and to sync data to CareLink™ system. The MiniMed™ Mobile app is not intended to replace the real-time display of Continuous glucose monitoring or insulin pump data on the primary display device (i.e., the insulin pump). All therapy decisions should be based on the primary display device. The MiniMed™ Mobile app is not intended to analyze or modify the continuous glucose monitoring data or insulin pump data that it receives. Nor is it intended to control any function of the connected continuous glucose monitoring system or insulin pump. The MiniMed™ Mobile app is not intended to receive information directly from the sensor or transmitter of a continuous glucose monitoring system.